Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2025Open Access

Multidrug-Resistant Bacteria (Superbugs): An Outlook on Emerging Global Health Threats

View Full Paper
Ask AI
Bookmark
Share

Authors

TDTiyasa DasSMSohaumn MondalDSDeodhar Singh

Discussion

Loading...

Member takes

Overview

This review reveals the rising challenge of antimicrobial resistance in global health, highlighting CRISPR and phage therapy as potential solutions.

Key Points

  • The emergence of multidrug-resistant superbugs poses a serious threat to global health and medicine.
  • By 2050, antimicrobial resistance is predicted to cause 8.22 million deaths due to excessive antibiotic use and horizontal gene transfer.
  • New strategies like β-lactamase inhibitors and phage therapy are vital to combat multidrug-resistant pathogens.
  • International collaboration and One Health-aligned policies are essential to manage and monitor antimicrobial resistance.

Cite This Study

Das et al. (2025) studied this question.

synapsesocial.com/papers/68ebc91af2c3e4d8d926e333https://doi.org/10.20944/preprints202510.0698.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in Antimicrobial Resistance (AMR) — Novel Therapeutic Strategies and Diagnostics2025
  2. 2A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation2025
  3. 3Emerging Therapeutic Treatments for Multidrug-Resistant Bacteria: A Review2025
  4. 4How to Prevent Out Bursts of Anti-Biotic resistant Bacterium using new Technology2025
  5. 5Unmasking the Silent Pandemic of Antimicrobial Resistance (AMR): A Comprehensive Review2025